Amyloid Monoclonal Antibody Treatment in PD Patients With Coexistent AD Pathology
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Clinical Trials Related to Lecanemab
Related studies linked through entity extraction aliases.
A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Deep Cervical Lymphatlc-Venous Anastomosis Surgery for the Treatment of Alzheimer's Disease: A Pilot Study (DIVA Study)
- Status
- RECRUITING
- Phase
- PHASE3
DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Feasibility of Lecanemab Registry and Clinical Outcome Measures
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Cognitive Neurology Unit Clinical Registry
- Status
- RECRUITING
- Phase
- N/A
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Standard of Care Monoclonal Antibody (mAb) Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Study of Subcutaneous Lecanemab in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3